Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · T-lymphoblastic Lymphoma

T-lymphoblastic Lymphoma

📧 Sign up to get email alerts when something new happens for T-lymphoblastic Lymphoma.

Top drugs studied for this disease

Venetoclax (2)
IM2 regimen (1)
Anti-CD1a CAR-T (1)
MabCampath (1)
S101 autologous anti-CD7 CAR-T cells (1)
CD5 CAR-T cells (1)
CD7-targeted CAR-T cell therapy (1)
CD7 CAR-T cell therapy (1)
Vincristine (1)
CYCLOPHOSPHAMIDE (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms